Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erritzoe

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Nordic Journal of Psychiatry|July 21, 2017
Lessons to be learned from early psychedelic therapy in DenmarkDavid Erritzoe, William A Richards
Neuropharmacology|September 30, 2022
Psychedelics therapeutics: What we know, what we think, and what we need to researchDavid Nutt, Meg Spriggs, David Erritzoe
Cell|April 4, 2020
Psychedelic Psychiatry's Brave New WorldDavid Nutt, David Erritzoe, Robin Carhart-Harris
History of Psychiatry|February 16, 2017
Concerns regarding conclusions made about LSD-treatments (received 25 October 2016)David Erritzoe, David J Nutt, Robin Carhart-Harris
The International Journal of Neuropsychopharmacology|April 21, 2025
Cigarette smoking is associated with levels of the serotonin transporter in the brain: a [11C]DASB PET StudyPaul Faulkner, Gitte M Knudsen, Vibe G Frokjaer, et al.
Scientific Reports|July 26, 2023
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosingBalázs Szigeti, David Nutt, Robin Carhart-Harris, et al.
Scientific Reports|June 9, 2023
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuascaBrandon Weiss, Aleksandra Wingert, David Erritzoe, et al.
Neuroimaging Clinics of North America|March 18, 2004
Positron emission tomography and single photon emission CT molecular imaging in schizophreniaDavid Erritzoe, Peter Talbot, W Gordon Frankle, et al.
Frontiers in Psychiatry|February 13, 2026
High hopes? Precision psychedelic addiction medicineRayyan Raja Zafar, Patrick Kleine, Danielle Kurtin, et al.
Journal of Psychopharmacology (Oxford, England)|May 8, 2018
Are ecstasy induced serotonergic alterations overestimated for the majority of users?Balázs Szigeti, Adam R Winstock, David Erritzoe, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Nordic Journal of Psychiatry|July 21, 2017
Lessons to be learned from early psychedelic therapy in DenmarkDavid Erritzoe, William A Richards
Neuropharmacology|September 30, 2022
Psychedelics therapeutics: What we know, what we think, and what we need to researchDavid Nutt, Meg Spriggs, David Erritzoe
Cell|April 4, 2020
Psychedelic Psychiatry's Brave New WorldDavid Nutt, David Erritzoe, Robin Carhart-Harris
History of Psychiatry|February 16, 2017
Concerns regarding conclusions made about LSD-treatments (received 25 October 2016)David Erritzoe, David J Nutt, Robin Carhart-Harris
The International Journal of Neuropsychopharmacology|April 21, 2025
Cigarette smoking is associated with levels of the serotonin transporter in the brain: a [11C]DASB PET StudyPaul Faulkner, Gitte M Knudsen, Vibe G Frokjaer, et al.
Scientific Reports|July 26, 2023
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosingBalázs Szigeti, David Nutt, Robin Carhart-Harris, et al.
Scientific Reports|June 9, 2023
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuascaBrandon Weiss, Aleksandra Wingert, David Erritzoe, et al.
Neuroimaging Clinics of North America|March 18, 2004
Positron emission tomography and single photon emission CT molecular imaging in schizophreniaDavid Erritzoe, Peter Talbot, W Gordon Frankle, et al.
Frontiers in Psychiatry|February 13, 2026
High hopes? Precision psychedelic addiction medicineRayyan Raja Zafar, Patrick Kleine, Danielle Kurtin, et al.
Journal of Psychopharmacology (Oxford, England)|May 8, 2018
Are ecstasy induced serotonergic alterations overestimated for the majority of users?Balázs Szigeti, Adam R Winstock, David Erritzoe, et al.
Pageof 15